← Compare landing
PSI vs Novotech
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | PSI | Novotech |
|---|---|---|
| Summary | PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases. | Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development. |
| Services |
|
|
| Modalities |
|
|
| Indications |
|
|
| Phases |
|
|
| Sourcing models |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/appian/novotech-cro.md